SecBot SecBot
Insider Buy ·Filed Aug 27, 2026

RGNX

REGENXBIO Inc.
BULLISH
Impact 5/10
Horizonweeks Processed2mo ago SEC0002023732-26-000008
Insider cluster: 1 insiders, $450K total
Actionable Insight ▲ Bullish

The director's cluster of open-market buys totaling ~$950K at ~$9.14-$9.36 per share signals insider conviction near current levels. Monitor for additional insider buying or upcoming catalysts (e.g., pipeline data, regulatory updates) that could validate this signal. The stock's 89% analyst bullish consensus and recent institutional accumulation (7 adds, 6 doubled) provide a supportive backdrop.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$9.66
T+0 close · Aug 27, 2026 · via day close
Latest settled
−22.67%
T+20 · $7.47 · next T+60 in 6d
Vs SPY
−22.93%
α at T+20
Latest observation
−0.49%
T+54 · FF3 residual α
  1. T+0 · Aug 28 $9.66entry
  2. T+1 · 3mo ago −1.66%α −1.36% · $9.50
  3. T+5 · 2mo ago −7.45%α −7.56% · $8.94
  4. T+20 · 7w ago −22.67%α −22.93% · $7.47
  5. T+55 · todayOpen
  6. T+60 · in 6d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Gregory Ciongoli made a $450K open-market purchase of RGNX shares at $9.14 on August 26, adding to a $500K purchase the prior day, bringing his total cluster buys to ~$950K. This is a standalone conviction buy by a director, representing ~0.15% of the $619M market cap, which is a modest but notable signal. The purchase follows a non-cash grant of 69,609 shares on August 25, suggesting the director is increasing his economic exposure beyond compensation.

Key Financial Metrics

Direction
buying
Total Value
$450.0K
Insiders
1

Key Facts

  • Director Gregory Ciongoli purchased 49,196 shares at $9.14 for $450K on August 26, 2026.
  • This follows a $500K purchase on August 25 and a non-cash grant of 69,609 shares on the same date.
  • Total insider buying in the last 30 days is $949K, all by this director.
  • The purchase represents ~0.15% of RGNX's $619M market cap, a modest but material signal.

Financial Impact

$450K open-market purchase by a director, representing ~0.15% of market cap.

insider ownership

Risk Factors

  • Single insider (director, not C-suite) limits signal strength; C-suite participation would be more compelling.
  • Biotech sector risk: pipeline setbacks or regulatory delays could reverse any near-term gains.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
89% bullish (19 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
INSIDER-BUY Data (Synthetic)0002023732-26-000008

Track record

15 reports on RGNX

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +29.65% at T+60 after the Jul 20, 2026 report. 3 of 5 went positive at some point.

Filters
  1. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $7.69 Now $7.32 −4.81% settles Feb 8
  2. Nov 5, 202611d ago 8-K Bearish 5/10 Entry $7.38 Now $7.32 +0.81% settles Feb 3
  3. Nov 4, 202612d ago Institutional Cluster Neutral 2/10 Entry $7.71 Now $7.32 −5.06% settles Feb 2
  4. Oct 16, 20264w ago 8-K Neutral 2/10 Entry $6.93 Now $7.32 +5.70% settles Jan 13
  5. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $7.26 Now $7.32 +0.83% settles Jan 8
  6. Aug 27, 202611w ago Insider Buy Bullish 5/10 Viewing Entry $9.66 Now $7.32 −24.22% settles Nov 23
  7. Aug 25, 202611w ago 8-K Neutral 3/10 Entry $9.38 Now $7.32 −21.96% settles Nov 19
  8. Aug 6, 202614w ago 8-K Bullish 7/10 Entry $11.28 to $7.41 Now $7.32 −35.11% ▼ −34.31% −32.88% vs SPY
  9. Aug 3, 202615w ago Press Release Neutral 1/10 Entry $9.96 to $6.59 Now $7.32 −26.51% ▼ −33.84% −35.62% vs SPY
  10. Jul 20, 202617w ago 8-K Bearish 6/10 Entry $10.32 to $7.26 Now $7.32 +29.07% ▲ +29.65% +34.49% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 6h 1m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 27, 2026